{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Epileptic encephalopathy",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_clobazam",
          "type": "Drug",
          "label": "Clobazam",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lacosamide",
          "type": "Drug",
          "label": "Lacosamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_levetiracetam",
          "type": "Drug",
          "label": "Levetiracetam",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lamotrigine",
          "type": "Drug",
          "label": "Lamotrigine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_topiramate",
          "type": "Drug",
          "label": "Topiramate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_valproate",
          "type": "Drug",
          "label": "Valproate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_zonisamide",
          "type": "Drug",
          "label": "Zonisamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rufinamide",
          "type": "Drug",
          "label": "Rufinamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_perampanel",
          "type": "Drug",
          "label": "Perampanel",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_carbamazepine",
          "type": "Drug",
          "label": "Carbamazepine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_eslicarbazepine",
          "type": "Drug",
          "label": "Eslicarbazepine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_phenobarbital",
          "type": "Drug",
          "label": "Phenobarbital",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_epileptic_encephalopathy",
          "type": "Disease",
          "label": "Epileptic Encephalopathy",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_gaba_receptor",
          "type": "Target",
          "label": "GABA Receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_gabaergic",
          "type": "Pathway",
          "label": "GABAergic Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_clobazam",
          "type": "Target",
          "label": "Clobazam Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_clobazam",
          "type": "Pathway",
          "label": "Clobazam Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_clobazam",
          "type": "Phenotype",
          "label": "Adverse Effects of Clobazam",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_lacosamide",
          "type": "Target",
          "label": "Lacosamide Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_lacosamide",
          "type": "Pathway",
          "label": "Lacosamide Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_lacosamide",
          "type": "Phenotype",
          "label": "Adverse Effects of Lacosamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_levetiracetam",
          "type": "Target",
          "label": "Levetiracetam Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_levetiracetam",
          "type": "Pathway",
          "label": "Levetiracetam Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_levetiracetam",
          "type": "Phenotype",
          "label": "Adverse Effects of Levetiracetam",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Clobazam",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Lacosamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Levetiracetam",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Lamotrigine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Topiramate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Valproate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Zonisamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Rufinamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Perampanel",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Carbamazepine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Eslicarbazepine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Phenobarbital",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_clobazam",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Clobazam is known to enhance GABA receptors."
        },
        {
          "source": "target_gaba_receptor",
          "target": "pathway_gabaergic",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "GABA receptors are central to GABAergic pathways."
        },
        {
          "source": "pathway_gabaergic",
          "target": "disease_epileptic_encephalopathy",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Disruption of GABAergic pathways is linked to epilepsy."
        },
        {
          "source": "drug_lacosamide",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Lacosamide is suggested to modulate sodium channels affecting GABA transmission."
        },
        {
          "source": "drug_levetiracetam",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Levetiracetam modulates synaptic transmission via GABA."
        },
        {
          "source": "drug_lamotrigine",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Lamotrigine affects voltage-gated sodium channels influencing GABA release."
        },
        {
          "source": "drug_topiramate",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Topiramate enhances GABAergic activity."
        },
        {
          "source": "drug_valproate",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Valproate increases GABA levels in the brain."
        },
        {
          "source": "drug_zonisamide",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Zonisamide modulates GABA-A receptor function."
        },
        {
          "source": "drug_rufinamide",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Rufinamide is thought to modulate neurotransmitter release."
        },
        {
          "source": "drug_perampanel",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Perampanel is an antagonist of AMPA receptors influencing GABA neurotransmission."
        },
        {
          "source": "drug_carbamazepine",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Carbamazepine enhances GABAergic inhibition."
        },
        {
          "source": "drug_eslicarbazepine",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Eslicarbazepine's action involves modulation of GABA."
        },
        {
          "source": "drug_phenobarbital",
          "target": "target_gaba_receptor",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Phenobarbital is a barbiturate that enhances GABA receptor activity."
        },
        {
          "source": "drug_clobazam",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Clobazam has been indicated for use in epileptic encephalopathy."
        },
        {
          "source": "drug_lacosamide",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Lacosamide is indicated for various epilepsy types."
        },
        {
          "source": "drug_levetiracetam",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Levetiracetam is commonly used to manage seizures."
        },
        {
          "source": "drug_lamotrigine",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Lamotrigine is effective for focal and generalized seizures."
        },
        {
          "source": "drug_topiramate",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Topiramate is used for epilepsy treatment."
        },
        {
          "source": "drug_valproate",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Valproate is a first-line treatment for epilepsy."
        },
        {
          "source": "drug_zonisamide",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Zonisamide is indicated for adjunctive treatment of seizures."
        },
        {
          "source": "drug_rufinamide",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Rufinamide is used for the treatment of seizures."
        },
        {
          "source": "drug_perampanel",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Perampanel is indicated as adjunctive therapy."
        },
        {
          "source": "drug_carbamazepine",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Carbamazepine is often prescribed for seizures."
        },
        {
          "source": "drug_eslicarbazepine",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Eslicarbazepine is used for drug-resistant seizures."
        },
        {
          "source": "drug_phenobarbital",
          "target": "disease_epileptic_encephalopathy",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Phenobarbital is a classic treatment for epilepsy."
        },
        {
          "source": "drug_clobazam",
          "target": "n_ot_clobazam",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_clobazam",
          "target": "n_rp_clobazam",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_clobazam",
          "target": "n_adv_clobazam",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致的不良表型"
        },
        {
          "source": "n_adv_clobazam",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将影响疗效"
        },
        {
          "source": "drug_lacosamide",
          "target": "n_ot_lacosamide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_lacosamide",
          "target": "n_rp_lacosamide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_lacosamide",
          "target": "n_adv_lacosamide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致的不良表型"
        },
        {
          "source": "n_adv_lacosamide",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将影响疗效"
        },
        {
          "source": "drug_levetiracetam",
          "target": "n_ot_levetiracetam",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_levetiracetam",
          "target": "n_rp_levetiracetam",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_levetiracetam",
          "target": "n_adv_levetiracetam",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致的不良表型"
        },
        {
          "source": "n_adv_levetiracetam",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将影响疗效"
        }
      ],
      "round_index": 1
    },
    "history": {
      "round": 1,
      "last_scores": []
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [],
    "notes": "final-only ablation; no interrupts."
  }
}